| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹15,139 | +0.93% | |
| 6 months | ₹30,000 | ₹31,161 | +3.87% | |
| 1 year | ₹60,000 | ₹67,430 | +12.38% | |
| 3 years | ₹1,80,000 | ₹2,16,088 | +20.05% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Repo | Unspecified | Repo | 21.10% |
| Zydus Lifesciences Ltd | Healthcare | Equity | 10.25% |
| Divi's Laboratories Ltd. | Healthcare | Futures | 9.92% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 9.83% |
| Glenmark Pharmaceuticals Limited | Healthcare | Futures | 9.38% |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | Equity | 8.89% |
| Strides Pharma Science Ltd | Healthcare | Equity | 8.79% |
| TORRENT PHARMACEUTICALS LTD^ | Healthcare | Futures | 8.46% |
| Pfizer Ltd | Healthcare | Equity | 7.14% |
| Ipca Laboratories Ltd | Healthcare | Equity | 5.37% |
| Biocon Ltd Futures | Healthcare | Futures | 5.06% |
| Zydus Wellness Ltd | Consumer Staples | Equity | 4.50% |
| LG Electronics India Ltd. | Consumer Discretionary | Equity | 3.34% |
| Colgate-Palmolive (India) Ltd | Consumer Staples | Equity | 3.18% |
| Dr. Reddy's Laboratories Ltd | Healthcare | Equity | 2.61% |
| Glenmark Life Sciences Ltd | Healthcare | Equity | 2.34% |
| GOVERNMENT OF INDIA 37816 091 DAYS TBILL 05NV26 FV RS 100 | Financial | Treasury Bills | 0.72% |
| GOVERNMENT OF INDIA 37846 091 DAYS TBILL 19NV26 FV RS 100 | Financial | Treasury Bills | 0.72% |
| GOVERNMENT OF INDIA 37861 091 DAYS TBILL 27NV26 FV RS 100 | Financial | Treasury Bills | 0.72% |
| 91 Days Treasury Bill 03-Dec-2026 | Financial | Treasury Bills | 0.72% |
| 91 DAYS TBILL RED 10-12-2026 | Financial | Treasury Bills | 0.72% |
| 91 DTB (17-DEC-2026) | Financial | Treasury Bills | 0.71% |
| 91 DTB (24-DEC-2026) | Financial | Treasury Bills | 0.71% |
| 91 Days Tbill (MD 14/01/2027) | Financial | Treasury Bills | 0.71% |
| 91 DAY T-BILL 28.01.27 | Financial | Treasury Bills | 0.71% |
| Sumitomo Chemical India Ltd | Materials | Equity | 0.19% |
| Net Payables | Unspecified | Net Payables | -26.80% |
| Name | 6M | 1Y | 3Y | All |
|---|---|---|---|---|
| Fund returns | +12.3% | +17.2% | +18.3% | +19.6% |
| Category average (Equity Sectoral) | +14.1% | +18.6% | +21.5% | +17.1% |
| Rank (Equity Sectoral) | -- | 15 | 14 | -- |